Utility of FibroScan-based scoring systems to narrow the risk group of nonalcoholic fatty liver disease with comorbidities

doi:10.4291/wjgp.v13.i3.96

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5168)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

272

WORD

HTML

1978

Figures (1-2)

207

Tables (1-4)

158

Sum=2704

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

292

Download

1073

Sum=1365

Publishing Process of This Article

Item

Count

Browse

331

Download

768

Sum=1099

May 22, 2022 (publication date) through Jun 29, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pathophysiology

ISSN

2150-5330

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastrointest Pathophysiol. May 22, 2022; 13(3): 96-106
Published online May 22, 2022. doi: 10.4291/wjgp.v13.i3.96

Table 4 The prevalence of esophagogastric varices in Baveno VI criteria and its derivatives

	Baveno VI		Exp. Baveno VI		New NASH C.C
	LSM	platelet	LSM	platelet	LSM	platelet
	< 20	150 <	< 25	110 <	< 30	110 <
EGV/rule in (n)	12/26		8/13		6/9
EGV/rule out (n)	13/165		17/178		19/182

Exp. Baveno VI: Expanded Baveno VI; New NASH C.C: New NASH cirrhosis criteria; LSM: Liver stiffness measurement (KPa); Platelet count (×10⁹/L); EVG: Esophagogastric varix.

Citation: Miura K, Maeda H, Morimoto N, Watanabe S, Tsukui M, Takaoka Y, Nomoto H, Goka R, Kotani K, Yamamoto H. Utility of FibroScan-based scoring systems to narrow the risk group of nonalcoholic fatty liver disease with comorbidities. World J Gastrointest Pathophysiol 2022; 13(3): 96-106
URL: https://www.wjgnet.com/2150-5330/full/v13/i3/96.htm
DOI: https://dx.doi.org/10.4291/wjgp.v13.i3.96